EGFR and neoplasm: The EGFR/ERK/MMP pathwayis known to promote tumor progression and metastasis across variouscancer types.37−39 To evaluate the impact of the combination treatmenton these signaling pathways, we analyzed the RNA and protein expressionlevels following the treatment.